These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 21261306)

  • 1. Nanomaterials in the environment: from materials to high-throughput screening to organisms.
    Thomas CR; George S; Horst AM; Ji Z; Miller RJ; Peralta-Videa JR; Xia T; Pokhrel S; Mädler L; Gardea-Torresdey JL; Holden PA; Keller AA; Lenihan HS; Nel AE; Zink JI
    ACS Nano; 2011 Jan; 5(1):13-20. PubMed ID: 21261306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of a multidisciplinary approach to solve complex nano EHS problems by the UC Center for the Environmental Implications of Nanotechnology.
    Xia T; Malasarn D; Lin S; Ji Z; Zhang H; Miller RJ; Keller AA; Nisbet RM; Harthorn BH; Godwin HA; Lenihan HS; Liu R; Gardea-Torresdey J; Cohen Y; Mädler L; Holden PA; Zink JI; Nel AE
    Small; 2013 May; 9(9-10):1428-43. PubMed ID: 23027589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ecological nanotoxicology: integrating nanomaterial hazard considerations across the subcellular, population, community, and ecosystems levels.
    Holden PA; Nisbet RM; Lenihan HS; Miller RJ; Cherr GN; Schimel JP; Gardea-Torresdey JL
    Acc Chem Res; 2013 Mar; 46(3):813-22. PubMed ID: 23039211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico analysis of nanomaterials hazard and risk.
    Cohen Y; Rallo R; Liu R; Liu HH
    Acc Chem Res; 2013 Mar; 46(3):802-12. PubMed ID: 23138971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicological aspects for nanomaterial in humans.
    Dusinska M; Magdolenova Z; Fjellsbø LM
    Methods Mol Biol; 2013; 948():1-12. PubMed ID: 23070759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening.
    Nel A; Xia T; Meng H; Wang X; Lin S; Ji Z; Zhang H
    Acc Chem Res; 2013 Mar; 46(3):607-21. PubMed ID: 22676423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
    Oberdörster G
    J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensors as tools for quantitation, nanotoxicity and nanomonitoring assessment of engineered nanomaterials.
    Sadik OA; Zhou AL; Kikandi S; Du N; Wang Q; Varner K
    J Environ Monit; 2009 Oct; 11(10):1782-800. PubMed ID: 19809701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The release of engineered nanomaterials to the environment.
    Gottschalk F; Nowack B
    J Environ Monit; 2011 May; 13(5):1145-55. PubMed ID: 21387066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creative use of analytical techniques and high-throughput technology to facilitate safety assessment of engineered nanomaterials.
    Liu Q; Wang X; Xia T
    Anal Bioanal Chem; 2018 Sep; 410(24):6097-6111. PubMed ID: 30066194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure science and the U.S. EPA National Center for Computational Toxicology.
    Cohen Hubal EA; Richard AM; Shah I; Gallagher J; Kavlock R; Blancato J; Edwards SW
    J Expo Sci Environ Epidemiol; 2010 May; 20(3):231-6. PubMed ID: 18985077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antibacterial effects of engineered nanomaterials: implications for wastewater treatment plants.
    Musee N; Thwala M; Nota N
    J Environ Monit; 2011 May; 13(5):1164-83. PubMed ID: 21505709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety of medicinal nanoproducts: new areas of toxicological research].
    Grudziński IP
    Rocz Panstw Zakl Hig; 2011; 62(3):239-46. PubMed ID: 22171512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transparent stakeholder engagement in practice: Lessons learned from applying comprehensive environmental assessment to research planning for nanomaterials.
    Powers C; Hendren C; Wang A; Davis JM
    Integr Environ Assess Manag; 2014 Oct; 10(4):498-510. PubMed ID: 24729532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.
    Tsuji JS; Maynard AD; Howard PC; James JT; Lam CW; Warheit DB; Santamaria AB
    Toxicol Sci; 2006 Jan; 89(1):42-50. PubMed ID: 16177233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of life cycle concepts for the development of safe nanoproducts.
    Som C; Berges M; Chaudhry Q; Dusinska M; Fernandes TF; Olsen SI; Nowack B
    Toxicology; 2010 Mar; 269(2-3):160-9. PubMed ID: 20025922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research strategy for evaluation methods of the manufactured nanomaterials in NIHS and importance of the chronic health effects studies].
    Hirose A; Nishimura T; Kanno J
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2009; (127):15-25. PubMed ID: 20306702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomaterial health effects--part 1: background and current knowledge.
    Powell MC; Kanarek MS
    WMJ; 2006 Mar; 105(2):16-20. PubMed ID: 16628969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced tools for the safety assessment of nanomaterials.
    Fadeel B; Farcal L; Hardy B; Vázquez-Campos S; Hristozov D; Marcomini A; Lynch I; Valsami-Jones E; Alenius H; Savolainen K
    Nat Nanotechnol; 2018 Jul; 13(7):537-543. PubMed ID: 29980781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.